Explore
EPR Effect-Based Tumor Targeted Nanomedicine
0 Ungluers have
Faved this Work
Login to Fave
I am honored to undertake the work for Guest Editor for this Special Issue of EPR Effect-Based Tumor Targeted Nanomedicine for the Journal of Personalized Medicine. It has already been 35 years since we published the concept of the EPR effect for the first time. The discovery of the new concept of EPR effect gave an impetus effect of growth momentum in nanomedicine, and numerous works are focused on tumor delivery, although the initial idea was based on vascular permeability in infection-induced inflamed tissue, where we discovered bradykinin in the key mediator of vascular permeability.I know, however, there are pros and cons to EPR effect. Cons stem either from a poor understanding of EPR effect, or somehow a biased view of the EPR effect, or from the tumor models being used, particularly in the clinical settings where vascular blood flow is so frequently obstructed. I hope scientists in the clinic, or basic researchers working on the tumor drug delivery, will join the forum of this Special Issue and express their data and opinions.The scope of this issue includes an in-depth understanding of the EPR effect, and issues associated with tumor microenvironment and also further exploitation of EPR effect in human cancer. In addition, new strategies for enhancement of the EPR effect using nanomedicine will be welcome, which is as important as the EPR effect itself. These papers cover not only cancer therapy, but also imaging techniques using nanofluorescent agents, including photodynamic therapy for inflammation, and boron neutron capture therapy.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 38 times via unglue.it ebook links.
- 38 - pdf (CC BY) at Unglue.it.
Keywords
- anaerobic bacteria
- Angiogenesis
- antioxidant
- arterial infusion
- bacterial therapy
- Bifidobacterium
- blood perfusion
- boron neutron capture therapy
- calcium phosphate
- Cancer
- cancer therapy
- cancer treatment
- canine cancer
- carbon-ion beam therapy
- chemoadjuvant
- Clinical & internal medicine
- combination therapy
- controlled release
- dasatinib
- DDS
- Diseases & disorders
- Drug delivery
- drug repurposing
- enhanced permeability and retention effect
- EPR
- EPR effect
- EPR-based therapy
- EPR-effect enhancers
- EPR-imaging techniques
- Extracellular matrix
- heterogeneity
- heterogeneity of the EPR effect
- HPMA copolymers
- hyaluronan
- hypoxia
- iDPS
- iNaD
- isosorbide dinitrate
- medicine
- Metabolism
- microenvironment
- microRNA
- n/a
- nanoformulation
- Nanomedicine
- nanomedicines
- Nanoparticles
- Nanotechnology
- nitric oxide donors
- oncology
- particle beam therapy
- passive targeting
- PEG blending
- phosphodiesterase 5 inhibitors
- photodynamic
- photodynamic therapy
- poly(styrene-co-maleic acid) micelles
- proton beam therapy
- Reactive Oxygen Species
- self-assembling drug
- sildenafil
- sildenafil citrate
- siRNA
- solid cancer
- solid-tumor
- targeted therapy
- targeting
- TNBC
- tumor
- tumor blood flow
- tumor targeting
- tumor vascular regulation
- tumor-selective drug delivery
- vascular permeability
- zinc protoporphyrin
Links
DOI: 10.3390/books978-3-0365-5427-3Editions